Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9683235
Compositions for modulating Tau expression
granted -
US 9683236
Modulation of huntingtin expression
granted -
US 9678060
Lunasin-induced regulation of disease-related gene expression
granted -
US 9677076
Modulation of hepatitis B virus (HBV) expression
granted -
US 9670549
Gene expression signatures of neoplasm responsiveness to therapy
granted -
US 9669064
Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or promoting expression of collagen using Ixora parviflora leaf extract
granted -
US 9673409
Phosphorescent tetradentate metal complexes having modified emission spectra
granted -
US 9669014
Small molecule inhibitors of superoxide dismutase expression
granted -
US 9670492
Modulation of prekallikrein (PKK) expression
granted -
US 9663790
Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
granted -
US 9663783
Modulation of alpha synuclein expression
granted -
US 9662424
Hydrogel membrane for adhesion prevention
granted -
US 9650352
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
granted -
US 9649358
Methods for use of neural stem cell compositions for treatment of central nervous system lesions
granted -
US 9649343
Compositions and methods for transplantation of colon microbiota
granted -
US 9650407
Reprogramming of cellular adhesion
granted -
US 9644207
Compositions and methods for modulating Tau expression
granted -
US 9636649
Dispersions comprising discrete carbon nanotube fibers
granted -
US 9637738
Methods and agents to increase therapeutic dystrophin expression in muscle
granted -
US 9636400
VEGF specific fusion protein antagonist formulations
granted -
US 9631193
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 9624496
Modulation of apolipoprotein C-III expression
granted -
US 9623124
Multimodal diagnostic technology for early stage cancer lesions
granted -
US 9623103
Arterivirus protein and expression mechanisms
granted